Sample preparation of mycobacterium tuberculosis extracts for nuclear magnetic resonance metabolomic studies

Journal of Visualized Experiments

Volumn , Issue 67, 2012, Pages

  Zinniel, Denise K ^a   Fenton, Robert J ^a   Halouska, Steven ^a   Powers, Robert ^a   Barletta, Raul G ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Cell extracts; Homogenizer; Infection; Issue 67; Lysis; Metabolomics; Mycobacterium tuberculosis; NMR; Sample preparation

Indexed keywords

ARTICLE; CHEMISTRY; METABOLISM; METABOLOMICS; METHODOLOGY; MYCOBACTERIUM TUBERCULOSIS; NUCLEAR MAGNETIC RESONANCE;

METABOLOMICS; MYCOBACTERIUM TUBERCULOSIS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR;

EID: 84868293631     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/3673     Document Type: Article

References (34)

1. Larsen, M.H., Biermann, K., Tandberg, S., Hsu, T., & Jacobs, W.R., Jr. Genetic Manipulation of Mycobacterium tuberculosis. Curr. Protoc. Microbiol. Chapter 10, Unit 10A 2 (2007).
2. Larsen, M.H., Biermann, K., & Jacobs, W.R., Jr. Laboratory Maintenance of Mycobacterium tuberculosis. Curr. Protoc. Microbiol. Chapter 10, Unit 10A 1 (2007).
3. Clarridge, J.E., 3rd, Shawar, R.M., Shinnick, T.M., & Plikaytis, B.B. Large-scale use of polymerase chain reaction for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory. J. Clin. Microbiol. 31, 2049-56 (1993).
4. Nguyen, B.D., Meng, X., Donovan, K.J., & Shaka, A.J. SOGGY: solvent-optimized double gradient spectroscopy for water suppression. A comparison with some existing techniques. J. Magn. Reson. 184, 263-74 (2007).
5. Cui, Q., et al. Metabolite identification via the Madison Metabolomics Consortium Database. Nat. Biotechnol. 26, 162-4 (2008).
6. Ulrich, E.L., et al. BioMagResBank. Nucleic Acids Res. 36, D402-8 (2008).
7. Wishart, D.S., et al. HMDB: the Human Metabolome Database. Nucleic Acids Res. 35, D521-6 (2007).
8. Kanehisa, M., et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res. 36, D480-4 (2008).
9. Karp, P.D., et al. Expansion of the BioCyc collection of pathway/genome databases to 160 genomes. Nucleic Acids Res. 33, 6083-9 (2005).
10. Halouska, S., et al. Use of NMR metabolomics to analyze the targets of D-cycloserine in mycobacteria: role of D-alanine racemase. J. Proteome. Res. 6, 4608-14 (2007).
11. Boshoff, H.I., et al. The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J. Biol. Chem. 279, 40174-84 (2004).
12. Mehaffy, C., et al. Descriptive proteomic analysis shows protein variability between closely related clinical isolates of Mycobacterium tuberculosis. Proteomics. 10, 1966-84 (2010).
13. Schnappinger, D., et al. Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment. J. Exp. Med. 198, 693-704 (2003).
14. Schnappinger, D. Schoolnik, G.K.& Ehrt, S. Expression profiling of host pathogen interactions: how Mycobacterium tuberculosis and the macrophage adapt to one another. Microbes. Infect. 8, 1132-40 (2006).
15. Shui, W., et al. Quantitative proteomic profiling of host-pathogen interactions: the macrophage response to Mycobacterium tuberculosis lipids. J. Proteome. Res. 8, 282-9 (2009).
16. Talaat, A.M., Lyons, R., Howard, S.T., & Johnston, S.A. The temporal expression profile of Mycobacterium tuberculosis infection in mice. Proc. Natl. Acad. Sci. U.S.A. 101, 4602-7 (2004).
17. Forgue, P., et al. NMR metabolic profiling of Aspergillus nidulans to monitor drug and protein activity. J. Proteome Res. 5, 1916-23 (2006).
18. Goodacre, R., Vaidyanathan, S., Dunn, W.B., Harrigan, G.G., & Kell, D.B. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol. 22, 245-52 (2004).
19. Shin, J.H., et al. (1)H NMR-based Metabolomic Profiling in Mice Infected with Mycobacterium tuberculosis. J. Proteome Res. 10, 2238-47 (2011).
20. Jaki, B.U., Franzblau, S.G., Cho, S.H., & Pauli, G.F. Development of an extraction method for mycobacterial metabolome analysis. J. Pharm. Biomed. Anal. 41, 196-200 (2006).
21. de Carvalho, L.P., et al. Metabolomics of Mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates. Chem. Biol. 17, 1122-31 (2010).
22. de Carvalho, L.P., et al. Activity-based metabolomic profiling of enzymatic function: identification of Rv1248c as a mycobacterial 2-hydroxy-3-oxoadipate synthase. Chem. Biol. 17, 323-32 (2010).
23. Marrero, J., Rhee, K.Y., Schnappinger, D., Pethe, K., & Ehrt, S. Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for Mycobacterium tuberculosis to establish and maintain infection. Proc. Natl. Acad. Sci. U.S.A. 107, 9819-24 (2010).
24. Tang, Y.J., et al. Central metabolism in Mycobacterium smegmatis during the transition from O2-rich to O2-poor conditions as studied by isotopomer-assisted metabolite analysis. Biotechnol. Lett. 31, 1233-40 (2009).
25. Kweon, O., et al. A polyomic approach to elucidate the fluoranthene-degradative pathway in Mycobacterium vanbaalenii PYR-1. J. Bacteriol. 189, 4635-47 (2007).
26. Hasan, M.R., Rahman, M., Jaques, S., Purwantini, E., & Daniels, L. Glucose 6-phosphate accumulation in mycobacteria: implications for a novel F420-dependent anti-oxidant defense system. J. Biol. Chem. 285, 19135-44 (2010).
27. Soga, T., et al. Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. J. Proteome Res. 2, 488-94 (2003).
28. Metz, T.O., et al. The future of liquid chromatography-mass spectrometry (LC-MS) in metabolic profiling and metabolomic studies for biomarker discovery. Biomark Med. 1, 159-185 (2007).
29. Ludwig, C. & Viant, M.R. Two-dimensional J-resolved NMR spectroscopy: review of a key methodology in the metabolomics toolbox. Phytochem. Anal. 21, 22-32 (2010).
30. Simpson, R.J. In Proteins and Proteomics: A Laboratory Manual. Inglis, J., ed., 425-595, Cold Spring Laboratory Press, (2003).
31. Beste, D.J. & McFadden, J. System-level strategies for studying the metabolism of Mycobacterium tuberculosis. Mol. Biosyst. 6, 2363-72 (2010).
32. Rhee, K.Y., et al. Central carbon metabolism in Mycobacterium tuberculosis: an unexpected frontier. Trends Microbiol. (2011).
33. Who. World Health Organization. Anti-tuberculosis Drug Resistance in the World: Report No. 4. (2008).
34. Jassal, M. & Bishai, W.R. Extensively drug-resistant tuberculosis. Lancet Infect Dis. 9, 19-30 (2009)